尿酸和妊娠糖尿病风险:一项观察性研究和孟德尔随机化分析
Nuerbiya Xilifu1,2, Rui Zhang1, Yongling Dai2
1Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai, 200240, China.
Reproductive biology and endocrinology : RB&E
|August 27, 2024
概括
怀孕早期血清尿酸 (UA) 高水平与妊娠期糖尿病 (GDM) 的风险增加有关. 然而,基因分析并未证实UA和GDM发展之间存在因果关系.
科学领域:
- 产科和妇科 产科和妇科
- 代谢障碍 代谢障碍 代谢障碍
- 流行病学 流行病学
背景情况:
- 在各种代谢条件下观察到血清尿酸 (UA) 升高.
- 了解UA在妊娠并发症 (如妊娠糖尿病) 中的作用对于母亲的健康至关重要.
研究的目的:
- 调查妊娠早期血清UA水平与发展GDM的风险之间的关联.
- 使用孟德尔随机化来确定UA和GDM之间是否存在因果关系.
主要方法:
- 一项病例控制研究,涉及684名患有GDM的女性和1162名对照.
- 使用条件后勤回归来评估UA和GDM风险之间的关系.
- 用两个样本的门德尔随机化分析来检查因果关系.
主要成果:
- 在较高的血清UA水平和GDM风险增加之间发现了显著的正相关性 (OR 1.967).
- 当UA水平超过222μmol/L时,UA和GDM风险之间观察到线性关系.
- 门德尔的随机化分析没有提供UA和GDM之间因果关系的证据 (OR 1.06).
结论:
- 怀孕早期血清UA水平与随后的GDM风险有积极的相关性.
- 尽管观察到这种关联,但遗传证据并不支持UA和GDM之间的因果关系.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes
908
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Dipeptidyl Peptidase 4 Inhibitors
179
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
179


